Komaru T, Ashikawa K, Kanatsuka H, Sekiguchi N, Suzuki T, Takishima T
First Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.
Circ Res. 1990 Nov;67(5):1142-51. doi: 10.1161/01.res.67.5.1142.
The purpose of this study was to determine whether neuropeptide Y has a direct vasoconstrictor effect at low doses, mimicking the physiological plasma concentration on the specific site(s) of coronary arterial microvessels in in situ beating canine left ventricles. Coronary microvessels were directly observed by means of an intravital microscope and video system equipped with a floating objective. Epi-illuminated fluorescence coronary microangiography was performed in open-chest anesthetized dogs (n = 14) to examine the changes in internal diameter of epimyocardial arterial microvessels. Flow velocity of fluorescently labeled microshperes in capillaries was also measured (n = 6). To eliminate secondary effects of neuropeptide Y on coronary microvessels via autonomic nervous modulation, experiments were conducted under pharmacological blockade of the regional autonomic nervous system by intracoronary injection of propranolol, 50 micrograms/kg; phentolamine, 100 micrograms/kg; and atropine, 5 micrograms/kg. Aortic pressure and heart rate were kept constant during the experiments. Intracoronary infusion of three different doses of neuropeptide Y (1, 10, and 100 pmol/kg/min) for 5 minutes significantly constricted small microvessels (less than 100 microns in diameter) (-5.2 +/- 1.4%, -8.5 +/- 1.5%, and -14.0 +/- 1.7%; p less than 0.05 versus before neuropeptide Y at each dose), medium microvessels (100-200 microns in diameter) (-5.5 +/- 1.6%, -10.6 +/- 1.8%, and -16.8 +/- 2.1%, p less than 0.05 versus before neuropeptide Y at each dose), and large microvessels (greater than 200 microns in diameter) (-3.6 +/- 0.6%, -5.8 +/- 0.8%, and -10.0 +/- 1.1%; p less than 0.05 versus before neuropeptide Y at each dose) in a dose-dependent manner. Capillary flow velocity was reduced by 17.2 +/- 3.1% by an intracoronary dose of 100 pmol/kg/min of neuropeptide Y (p less than 0.05). The present study indicates that low doses of neuropeptide Y exert a homogeneous direct vasoconstrictor effect on various sizes of coronary arterial microvessels and reduce capillary flow velocity. These results suggest that neuropeptide Y may play a physiological role in modulating coronary microvascular tone.
本研究的目的是确定低剂量的神经肽Y是否具有直接的血管收缩作用,即模拟生理血浆浓度对原位搏动的犬左心室冠状动脉微血管特定部位的作用。通过配备浮动物镜的活体显微镜和视频系统直接观察冠状动脉微血管。在开胸麻醉犬(n = 14)中进行落射荧光冠状动脉微血管造影,以检查心外膜动脉微血管内径的变化。还测量了毛细血管中荧光标记微球的流速(n = 6)。为消除神经肽Y通过自主神经调节对冠状动脉微血管的继发作用,在冠状动脉内注射普萘洛尔(50微克/千克)、酚妥拉明(100微克/千克)和阿托品(5微克/千克)对局部自主神经系统进行药理阻断的情况下进行实验。实验过程中主动脉压和心率保持恒定。冠状动脉内输注三种不同剂量的神经肽Y(1、10和100皮摩尔/千克/分钟)5分钟,显著使小微血管(直径小于100微米)收缩(-5.2±1.4%、-8.5±1.5%和-14.0±1.7%;各剂量下与神经肽Y注射前相比,p<0.05),中微血管(直径100 - 200微米)收缩(-5.5±1.6%、-10.6±1.8%和-16.8±2.1%,各剂量下与神经肽Y注射前相比,p<0.05),大微血管(直径大于200微米)收缩(-3.6±0.6%、-5.8±0.8%和-10.0±1.1%;各剂量下与神经肽Y注射前相比),呈剂量依赖性。冠状动脉内注射100皮摩尔/千克/分钟的神经肽Y使毛细血管流速降低17.2±3.1%(p<0.05)。本研究表明,低剂量的神经肽Y对各种大小的冠状动脉微血管均有均匀的直接血管收缩作用,并降低毛细血管流速。这些结果提示神经肽Y可能在调节冠状动脉微血管张力中发挥生理作用。